Profusa, Inc.

Profusa, Inc., operating under the ticker symbol NVAC, is a biomedical device company focused on tissue-integrated biosensor technology designed for continuous physiological monitoring. The company filed its annual 10-K report with the Securities and Exchange Commission on March 6, 2023, reflecting its status as a post-merger public reporting entity following its special purpose acquisition transaction. Profusa operates in the healthcare and medical-device sector, with its core platform centered on subcutaneous sensor systems capable of real-time measurement of key biological markers in tissue. Investors and analysts seeking full filing history, transaction details, and SPAC analytics for NVAC are invited to sign up for complete data coverage at SpacDesk.